Edgewell Personal Care Company

NYSE:EPC

Household & Personal Products

Consumer Defensive
$28.25 +5.59%

+$1.26 today

Market cap
$1.30B
Beta
0.49
P/E (TTM)
-14.2
EPS (TTM)
-$1.67
Dividend yield
2.52%
52W Low $15.73High $27.24

Volume 0.50M

Average 0.79M

EPC Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

Edgewell Personal Care CompanyNYSE: EPC

Research & Development · Q2 FY2026 · quarter ended Mar 2026

Research & development growth accelerates

Q2 FY2026 research & development of $14.9M rose 7.2% year over year, ahead of the -0.3% change in trailing-twelve-month research & development. Sequentially, it rose 8.0% from the prior quarter. Over 3 fiscal years it compounded at +1.2% a year.

Context

  • Research & development amounted to 2.6% of revenue in FY2025, unchanged from a year earlier.
  • Research & development increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +7.2% holds above the trailing-twelve-month pace of -0.3%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$14.9M+8.0% QoQ
Last fiscal yearSep 2025
$57.6M-1.4% YoY
LTMMar 2026
$58.5M-0.3% YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+7.2%——
1 year-1.4%——
3-year CAGR+1.2%——
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
57.6M USD
Year-over-year change
-1.4%
4-year CAGR
-0.1%

Research & Development vs competitors

How EPC compares with its peers on the latest reported figures

  • EPC's LTM Mar 2026 research & development of $58.5M is the highest of the 9 companies compared; the peer median is $0.
  • Its year-over-year change of -0.3% is the highest of 3, against a peer median of -38.3%.
  • Research & development amounts to 2.8% of revenue for EPC, versus a peer median of 0.0%.
EPC Competitors Peer median
Research & Development for EPC and competitors
Company Period LTM YoY 3-year CAGR% of revenue
EPCEdgewell Personal Care CompanyLTM Mar 2026$58.5M -0.3%+1.2%2.8%
NUSNu Skin Enterprises, Inc.LTM Mar 2026$10.8M -16.9%—0.7%
SPBSpectrum Brands Holdings, Inc.LTM Jun 2026$10.7M -59.8%—0.4%
HLFHerbalife Nutrition Ltd.LTM Mar 2026$0 ——0.0%
UTZUtz Brands, Inc.LTM Mar 2026$0 ——0.0%
SENEASeneca Foods CorporationLTM Mar 2026$0 ——0.0%
AVOMission Produce, Inc.LTM Apr 2026$0 ——0.0%
JBSSJohn B. Sanfilippo & Son, Inc.LTM Mar 2026$0 ——0.0%
NGVCNatural Grocers by Vitamin Cottage, Inc.LTM Mar 2026$0 ——0.0%
Peer median (excluding EPC) $0-38.3%—0.0%

Competitors are the stored peer set for EPC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Sep 2021
FY2022
Sep 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Revenue2.09B2.17B2.25B2.25B2.22B
Cost of Revenue1.14B1.29B1.31B1.3B1.3B
Gross Profit951.2M880.5M940.8M955.7M924.9M
Gross Margin45.6%40.5%41.8%42.4%41.6%
Research & Development57.8M55.5M58.5M58.4M57.6M
Selling, General & Admin632.7M627.4M638.7M662.1M671.7M
Operating Expenses711.3M698.2M713.8M756.4M828.3M
Depreciation & Amortization87.1M89.9M91.4M88M88.8M
EBITDA302.1M285.4M317.6M285.4M185.6M
EBITDA Margin14.5%13.1%14.1%12.7%8.3%
Operating Income239.9M182.3M227M199.3M96.6M
Operating Margin11.5%8.4%10.1%8.8%4.3%
Interest Income00000
Interest Expense67.9M71.4M78.5M76.5M73.2M
Other Income / Expenses(92.8M)(58.2M)(79.3M)(78.4M)(73M)
Income Before Tax147.1M124.1M147.7M120.9M23.6M
Pre-Tax Margin7.0%5.7%6.6%5.4%1.1%
Income Tax Expense29.3M24.6M33M22.3M(1.8M)
Net Income117.8M99.5M114.7M98.6M25.4M
Net Margin5.6%4.6%5.1%4.4%1.1%
EPS (Basic)2.151.872.241.980.53
EPS (Diluted)2.121.862.211.970.53
Weighted Avg Shares54.4M53.1M51.2M49.7M47.5M
Weighted Avg Shares (Diluted)55.2M53.6M51.8M50.1M47.6M

Edgewell Personal Care Company

NYSE:EPC

Intrinsic Alpha fair value

Locked

Current Price

$28.25

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.